StemCells Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (51)

View All

Latest Posts

About This Stock More About This Stock
StemCells Inc. Stops Phase 2 Study, To Shut Down Operations
Article By: Terry Chrisomalis
Wednesday, June 1, 2016 12:03 AM EDT
After failure of its lead product in clinical study, the company announces plans to shut down not only the study but the whole shebang.
In this article: D-STEM (DEFUNCT)
Read
StemCells, Inc. Announces 1-for-12 Reverse Stock Split
Article By: NASDAQ GlobeNewswire
Saturday, May 7, 2016 4:47 PM EDT
StemCells, Inc. (STEM) stockholders voted to approve a reverse stock split of the Company's common stock at a ratio of 1-for-12.
In this article: D-STEM (DEFUNCT)
Read
Wall Street’s Week Ahead: Nike Inc., StemCells Inc., Petroleo Brasileiro SA Petrobras
Article By: TipRanks
Sunday, March 20, 2016 11:00 PM EDT
Product innovation, restructuring plans, falling oil prices, and debt levels color this week’s earnings reports. Let’s take a closer look at what analysts are looking for from these companies.
In this article: NKE, PBR, D-STEM (DEFUNCT)
Read
Cantor Fitzgerald's Caroline Corner: Cutting-Edge Devices And Diagnostics Deliver Drugs And Profits
Article By: The Life Sciences Report
Tuesday, August 4, 2015 11:47 AM EDT
Caroline Corner of Cantor Fitzgerald follows companies with technologies that can both address dire diseases and reap windfalls for investors. Corner brings important names to investors' attention.
In this article: AGN, AEMD, CERS, D-STEM (DEFUNCT), NVIV, AERI, GKOS Also: RHHBY, ALIM, REGN, ONVO, XENT, MRK
Read
My Secrets To 297%+ Gains In Biotech Investing
Article By: Bret Jensen
Tuesday, May 12, 2015 5:50 PM EDT
Over the years, I have a developed a strategy I have dubbed “Shotgun Investing” for the small cap biotech arena. This involves holding many small stakes in myriad promising smaller concerns...
In this article: D-STEM (DEFUNCT), JUNO, KITE, ZIOP, NVAX, LCI, ZLTQ
Read
All Posts

Latest Tweets for $D.STEM (Defunct)

No tweets yet!

PARTNER HEADLINES